Eligibility Prostate Cancer NCT00685516

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject consents to participate in the trial.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
Description

Age | Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007112
scheduled to undergo radical prostatectomy.
Description

Radical prostatectomy Scheduled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0205539
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
Description

Tea Consumption Discontinuation | Tea Product Consumption Discontinuation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0039400
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0039400
UMLS CUI [2,2]
C1514468
UMLS CUI [2,3]
C0009830
UMLS CUI [2,4]
C1444662
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
Description

Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242295
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0681579
UMLS CUI [2,2]
C0009830
UMLS CUI [2,3]
C1444662
UMLS CUI [3]
C0065331
UMLS CUI [4]
C0042874
UMLS CUI [5]
C0036581
UMLS CUI [6]
C0061202
UMLS CUI [7,1]
C1504473
UMLS CUI [7,2]
C0009830
UMLS CUI [7,3]
C1444662
UMLS CUI [8]
C0771607
UMLS CUI [9]
C0756934
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of hepatitis or liver dysfunction
Description

Hepatitis | Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0086565
ongoing alcohol abuse
Description

Alcohol abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0085762
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
Description

Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C2700379
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C2700379
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
Description

Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0039400
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0039400
UMLS CUI [2,3]
C1514468
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0039400
UMLS CUI [3,3]
C0242295
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C0039400
UMLS CUI [5,1]
C1527304
UMLS CUI [5,2]
C0039400
UMLS CUI [5,3]
C1514468
UMLS CUI [6,1]
C1527304
UMLS CUI [6,2]
C0039400
UMLS CUI [6,3]
C0242295
allergy or sensitivity to multiple food items or nutritional supplements
Description

ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements

Type de données

boolean

Alias
UMLS CUI [1]
C0744084
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0242295
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
Description

Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride

Type de données

boolean

Alias
UMLS CUI [1]
C1518041
UMLS CUI [2]
C2936804
UMLS CUI [3]
C0060389
prior bilateral orchiectomy
Description

Bilateral orchiectomy

Type de données

boolean

Alias
UMLS CUI [1]
C0007347

Similar models

Eligibility Prostate Cancer NCT00685516

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
subject consents to participate in the trial.
boolean
C0021430 (UMLS CUI [1])
Age | Adenocarcinoma of prostate
Item
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
boolean
C0001779 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
Radical prostatectomy Scheduled
Item
scheduled to undergo radical prostatectomy.
boolean
C0194810 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Tea Consumption Discontinuation | Tea Product Consumption Discontinuation
Item
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
boolean
C0039400 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0039400 (UMLS CUI [2,1])
C1514468 (UMLS CUI [2,2])
C0009830 (UMLS CUI [2,3])
C1444662 (UMLS CUI [2,4])
Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES
Item
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
boolean
C0242295 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0681579 (UMLS CUI [2,1])
C0009830 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0065331 (UMLS CUI [3])
C0042874 (UMLS CUI [4])
C0036581 (UMLS CUI [5])
C0061202 (UMLS CUI [6])
C1504473 (UMLS CUI [7,1])
C0009830 (UMLS CUI [7,2])
C1444662 (UMLS CUI [7,3])
C0771607 (UMLS CUI [8])
C0756934 (UMLS CUI [9])
Item Group
C0680251 (UMLS CUI)
Hepatitis | Liver Dysfunction
Item
history of hepatitis or liver dysfunction
boolean
C0019158 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Alcohol abuse
Item
ongoing alcohol abuse
boolean
C0085762 (UMLS CUI [1])
Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor
Item
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
boolean
C3843040 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2700379 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C2700379 (UMLS CUI [2,3])
Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements
Item
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
boolean
C0020517 (UMLS CUI [1,1])
C0039400 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0039400 (UMLS CUI [2,2])
C1514468 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0039400 (UMLS CUI [3,2])
C0242295 (UMLS CUI [3,3])
C1527304 (UMLS CUI [4,1])
C0039400 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0039400 (UMLS CUI [5,2])
C1514468 (UMLS CUI [5,3])
C1527304 (UMLS CUI [6,1])
C0039400 (UMLS CUI [6,2])
C0242295 (UMLS CUI [6,3])
ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements
Item
allergy or sensitivity to multiple food items or nutritional supplements
boolean
C0744084 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride
Item
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
boolean
C1518041 (UMLS CUI [1])
C2936804 (UMLS CUI [2])
C0060389 (UMLS CUI [3])
Bilateral orchiectomy
Item
prior bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])